Novo Nordisk (NYSE: NVO)
Novo Nordisk Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Novo Nordisk Company Info
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
News & Analysis
Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy?
Their joint project is cutting-edge, but it won't pay off immediately.
Uncovering Hidden Gems: 1 AI-Powered Healthcare Stock Set to Dominate the Market
Artificial intelligence (AI) could play a big role in medical breakthroughs.
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
Novo Nordisk's New Weight Loss Drug Could Be Better Than Ozempic and Wegovy
Has Novo Nordisk's already red-hot stock become an even better buy?
Will Novo Nordisk Overtake Eli Lilly as the Most Valuable Healthcare Stock?
The gap has been shrinking between these stocks over the past month.
Is Novo Nordisk on the Verge of Another Blockbuster Drug?
Novo Nordisk just received some positive news for its latest obesity drug, amycretin.
Did Novo Nordisk Just Get a Jump on Eli Lilly?
A recent FDA announcement may have just put one company in the lead.
Novo Nordisk Isn't in The "Magnificent Seven," but Here's Why I Think It Should Be
The drugmaker is magnificent in its own right.
Valuation
Earnings Transcripts
Novo Nordisk (NVO) Q4 2023 Earnings Call Transcript
NVO earnings call for the period ending December 31, 2023.
Novo Nordisk (NVO) Q3 2023 Earnings Call Transcript
NVO earnings call for the period ending September 30, 2023.
Novo Nordisk (NVO) Q2 2023 Earnings Call Transcript
NVO earnings call for the period ending June 30, 2023.
Novo Nordisk (NVO) Q1 2023 Earnings Call Transcript
NVO earnings call for the period ending March 31, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.